BPH - Benign Prostatic Enlargement - Results from #460

REVIEW UroToday

Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia. September 11, 2022

Increased COX-1 expression in benign prostate epithelial cells is triggered by mitochondrial dysfunction. September 5, 2022

Functional and surgical outcomes of Aquablation in elderly men. September 4, 2022

Prostate Infiltration by Treg and Th17 Cells as an Immune Response to Propionibacterium acnes Infection in the Course of Benign Prostatic Hyperplasia and Prostate Cancer. August 29, 2022

Comparison of PKRP and TUVP in the treatment of high-risk BPH and analysis of postoperative influencing factors. August 28, 2022

Risk of prostate cancer and death after benign transurethral resection of the prostate-A 20-year population-based analysis. August 22, 2022

Prostate Artery Embolization and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis. August 21, 2022

A Novel Nomogram Based on Initial Features to Predict BPH Progression. August 15, 2022

Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk. August 14, 2022

Clinical significance of distally located periurethral calcification in patients with lower urinary tract symptoms of benign prostate hyperplasia. August 14, 2022

Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. August 8, 2022

Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia. August 7, 2022

The role of testosterone in men's health: is it time for a new approach? August 7, 2022

Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases. August 1, 2022

Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study. July 31, 2022

Evolution of healthcare costs for lower urinary tract symptoms associated with benign prostatic hyperplasia. July 31, 2022

Comparison of Tamsulosin and Tadalafil effects in LUTS treatment considering patients' atherosclerosis risk level. July 25, 2022

UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update. July 24, 2022

Supraspinal Neural Changes in Men with Benign Prostatic Hyperplasia Undergoing Bladder Outlet Procedures: a Pilot Functional MRI Study. July 24, 2022

Comparison of effectiveness and postoperative complications of different surgical methods in the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis based on randomized controlled trials. July 17, 2022

Page 24 of 140